Aims: Although cognitive dysfunction is a common neurological complication in elderly patients with diabetes, the mechanisms underlying this relationship remain unclear, and effective preventive interventions have yet to be developed. Thus, this study investigated the preventive effects and mechanisms of action associated with granulocyte colony-stimulating factor (G-CSF) on cognitive dysfunction in elderly diabetic mice with cerebral small vessel disease.
| INTRODUCTION
Diabetes is a very common metabolic disease that is associated with a variety of chronic complications, particularly in aging patients. Animal models and clinical assessments of diabetic patients have revealed that diabetes causes several abnormalities at both the chemical and the ultrastructural levels of the brain, results in dysfunctional neurological behaviors, and increases the risk of major depressive disorder.
1 Although accumulating evidence indicates that oxidative stress, 2-7 chronic inflammation, 4,6-10 and programmed cell death may result in the brain dysfunction associated with many neurological diseases, [11] [12] [13] the precise mechanisms underlying diabetes-related neurological disorders remain unclear.
Autophagy is a crucial process involving self-eating that cleans abnormal aggregated proteins and dysfunctional organelles from the brain 14 by removing damaged materials via acid hydrolases within the lysosomal system. Several studies have shown that the control of autophagocytosis is impaired in many neurodegenerative diseases. [15] [16] [17] The
Beclin1 protein is a core element of autophagy; the post-translational modifications of the Beclin1 interactome components include the Beclin1 protein, Bcl-2 family, Type 3 phosphatidyl inositol 3 kinase (T3PI3K), and autophagy-related 14 homolog (ATG14L), which is activated to produce phosphatidyl inositol-3 kinase (PI3K). These factors are known to play important roles in the regulation of cellular autophagy, 18 and it was recently shown that Beclin1-mediated autophagy is involved in several neurological diseases. 19, 20 However, its precise role in diabetes-induced cognitive dysfunction remains unclear.
Nuclear factor-κB (NF-κB) is a transcriptional factor that regulates inflammatory gene expression. It plays a crucial role in the synthesis of various cytokines, including tumor necrosis factor-α (TNF-α), interleukin (IL)-1β, IL-6, and IL-8, and regulates the expression of cyclooxygenase-2 (COX-2). 21 High glucose levels activate NF-κB, which, in turn, leads to increases in the expression of inflammatory cytokines.
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Therefore, it was hypothesized that NF-κB would be involved in diabetes-related cognitive dysfunction.
Granulocyte colony-stimulating factor (G-CSF) is a glycoprotein that promotes the production of granulocytes and stem cells in bone marrow as well as their release into the blood stream, which aids in the proliferation and differentiation of neurotrophic factors. 23 A previous study from our research group found that G-CSF might protect human brain vascular endothelial cells against injury induced by high glucose levels, free fatty acids, and hypoxia via the mitogen-activated protein kinase (MAPK) and protein kinase B (Akt) signaling pathways. 24 Therefore, this study aimed to investigate whether G-CSF would have preventive intervention effects on cognitive dysfunction in elderly diabetic mice with cerebral small vessel disease and whether Beclin1-mediated autophagy and NF-κB would be involved in these beneficial effects. Additionally, potential intervention methods against the occurrence and development of diabetic cognitive dysfunction were evaluated.
| MATERIALS AND METHODS

| Animal Grouping and Intervention
Male db/db and wild-type (WT) C57BL6/J mice were purchased from the Model Animal Research Center of Nanjing University (Nanjing, China) and housed under a 12-hour light/dark cycle in a humidity-and temperaturecontrolled environment with ad libitum access to water and standard laboratory chow. All animal experiments were approved by Fudan University Animal Care and Use Committee. At 3 weeks of age, the mice were randomly divided into WT-control (WG), WT+G-CSF (WGG), db/db-control (DG), and db/db+G-CSF (DGG) groups (n=10 for each group). All animals were provided with a normal diet for the duration of the study. DGG mice; (v) HE staining revealed fewer neurons in the hippocampus in DG mice; (vi) TEM analyses revealed significantly fewer autophagosomes in the hippocampi of DG mice, but G-CSF did not increase these numbers; (vii) there were significant reductions in mechanistic target of rapamycin (mTOR) and LC3-phosphatidylethanolamine conjugate (LC3)-II/I levels in the hippocampi of DG mice, whereas p62 was upregulated, and G-CSF significantly enhanced the levels of Beclin1, mTOR, and LC-II/I in DGG mice;
and (viii) G-CSF significantly reversed increases in nuclear factor κB (NF-κB) protein levels in DG but not in WG mice.
Conclusions:
In this study, aged diabetic mice were prone to cognitive dysfunction and cerebral small vessel disease. However, administration of G-CSF significantly improved cognitive function in elderly db/db diabetic mice, and this change was likely related to the regulation of autophagy and NF-κB signaling pathways.
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As the drawing site and the specific division zone described in Figure 1A , beginning. Beginning at the age of 6 months, the mice in the study groups received intraperitoneal injections of G-CSF (75 μg/kg, Chugai Pharmaceutical; Tokyo, Japan) for 1 month, whereas the control mice received intraperitoneal injections of an equal volume of normal saline at the corresponding time. At the age of 7.5 months, all the mice were detected by social test and Y-maze. Afterward, at the age of 8 months, three mice of each group underwent MR scanning. All the mice were sacrificed at the age of 8.5 months about 2 week after completing MRI examination, then were detected with transmission electron microscope, and were evaluated using immunohistochemistry and Western blot analyses. Random blood glucose levels were detected using caudal venous blood, and mice with levels glucose levels >16.7 mmol/L were considered to be diabetic mice. 25 
| Behavioral tests
All behavioral tests were observed by examiners blind to the conditions; the schedule is presented in Figure 1A .
| Y-maze test
The box for the Y-maze consisted of three identical arms that were 45 cm in length and 10 cm in height ( Figure 2A ). The mice were randomly placed into one of the three arms, and the number of entries into different arms during a 10-minute test period was recorded. Alternation was defined as continuous entry into three different arms (eg, 1, 2, and 3 or 3, 1, and 2). The final value included the number of actual alternations and maximum alternations and was calculated as follows: (actual alternation/maximum alternation)×100%; the percentages reflect the memory ability for each of the groups.
| Social Choice Test
The Social Choice Test was developed by Moy et al. 26 to assess social behaviors in animals.
| Acclimation
First, the mice were placed in the central compartment of the test box ( Figure 2B ), and their overall activity in the arena was automatically recorded with a video camera during a 10-minute habituation period.
At this stage, all compartments were empty, and the animals were allowed to freely explore the novel box.
| Sociability test
Next, the mice were placed in the central compartment with the apertures closed and allowed to explore the central chamber for 
| Social novelty test
Following the sociability testing, the mice were again confined to the central compartment, and a novel stranger (Stranger 2) was introduced to the empty compartment in the box. The study design was random; thus, Stranger 1 could remain in place or shift to the opposite side. Social memory was quantified during a 5-minute test period that began 30 seconds after the sociability test; activities in the respective compartments and the social contact zone were recorded. This test was repeated with delays of up to 10 minutes between the sociability test and the social memory retention test. The three-chamber box was cleaned with soapy water and disinfected with 70% ethanol between the testing of each subject.
| Blood pressure detection
Blood pressure (BP) was measured with a noninvasive computer- (E) Effects of G-CSF on social memory; during social novelty preference testing, the WT groups showed a preference for Stranger 2 (novel), but this did not significantly differ from that for Stranger 1 (all *P<.05). The differences among the four groups were not statistically significant (all *P<.05; n=10)
| Magnetic resonance imaging and functional magnetic resonance imaging scans
A Bruker 3.1 7T super conducting magnetic resonance imaging (MRI) scanner that included a microscope coil (diameter: 47 mm) was used to perform the MRI analyses. Prior to the MR scanning, the mice were anesthetized with 5% isoflurane and secured onto the fixed frame. T1, T2, and enhanced scans were performed using the following parameters: echo time=20 seconds, repetition time=2000 ms, band width=333 333.3 Hz, layers=16; layer thickness=0.8 mm, image size=64, and scanning field of view=21 600=15 000 mm.
A rapid acquisition with relaxation enhancement (RARE) sequence was used to acquire the brain anatomy images, whereas functional data were collected using a gradient echo sequence. A Fourier trans- Then, the results chart was shaped to cover a map of the mouse brain to determine the locations of signal changes.
| Transmission electron microscopy
For the transmission electron microscopy (TEM) procedure, brain tissues were perfused with 2.5% glutaraldehyde perfusate (25% glutaraldehyde and 0.2 mol/L phosphate buffer with 3 mmol/L MgCl 2 , pH 7.4) and then fixed with 2.5% glutaraldehyde. Following the fixation and dehydration steps, the brain tissues were embedded in paraffin, sliced, and stained with 3% uranyl acetate and lead citrate. Finally, the slices were observed using TEM (CM-120, Philips; Amsterdam, the Netherlands).
| Western blot analyses
The Western blot analyses were performed as previously described. 30 Briefly, hippocampal tissues from each mouse were homogenized with a radioimmunoprecipitation assay (RIPA) buffer (Beyotime Biotechnology; Shanghai, China), the tissue lysates were centrifuged at 1 34 000 g for 5 minutes, and the supernatant samples were collected to determine the protein concentrations with a bicinchoninic acid protein assay (Beyotime Institute of Biotechnology). The membranes were then reprobed with an antibody specific against GAPDH as an internal control. The specific primary antibodies used were as follows: Boster, Wuhan, China). Finally, photosensitive X-ray films were developed and fixed in a dark room to visualize the protein concentrations.
| HE staining
For the hematoxylin and eosin (HE) staining, paraffin-embedded sections were dewaxed and fixed with 95% ethanol for 20 minutes, washed twice with phosphate-buffered saline (PBS), and then immersed in a hematoxylin staining solution for 2-3 minutes to stain the nuclear components. Next, the slices were re-washed with water and immersed in an eosin staining solution for 1 minute to stain the cytoplasm.
| Immunohistochemistry analysis
For the immunohistochemistry procedure, paraffin-embedded sections were dewaxed and then repaired using ethylenediaminetetraacetic acid (EDTA) antigen retrieval buffers. Next, the sections were incubated with rabbit polyclonal antibodies for Beclin1 (1:500; Santa Cruz), LC3 (1:200; Cell Signaling Technology), and NF-κB (1:500; Santa Cruz) in PBS containing 3% bovine serum albumin (BSA) overnight at 4°C.
The samples were then incubated with an anti-rabbit secondary antibody (DAKO, Santa Clara, CA, USA) for 45 minutes at room temperature. Next, the sections were stained using a 3,3′-diaminobenzidine (DAB) procedure, and the nuclei were restained using hematoxylin.
Finally, the samples were mounted on slides for image analysis.
| Statistical analysis
All statistical analyses were performed using the GraphPad Prism 6.0 
| RESULTS
| Db/db mice had higher body weight and random blood glucose levels than WT mice
Body weight and blood glucose measurements were conducted from 4 weeks of age to 32 weeks of age. Both the body weight and blood glucose values of the db/db mice (DG and DGG) were significantly higher than those of the WT mice (*P<.05; Figure 1B ,C). There were no differences in systolic BP, which was assessed using the tail artery, among the four groups ( Figure 1D ).
| G-CSF improved cognitive impairments in diabetic mice
The Y-maze test measures working memory and spatial memory capacities. In this study, there was a significant decrease in the alternation percentage of the DG mice compared with the other three groups (P<.05), but G-CSF treatment significantly reversed this decrease.
These findings indicate that G-CSF improved working memory and spatial memory in db/db mice (Figure 2A,C) .
During the adaptation and acclimation stages of the Social Choice
Test, none of the groups exhibited a preference for the empty cages.
During the social behavior stage, all four groups exhibited a preference for Stranger 1 (C1; *P<.05). The social search time of DGG mice was not prolonged than other three groups, but it tends to that of WT groups mice. These findings indicate that the db/db diabetic mice were more likely to be in contact with a partner and participate in social activities and that G-CSF aided in normalizing social tendencies ( Figure 2B,D) . During the social novelty preference stage of the Social Choice Test, the two WT groups exhibited more contact with Stranger 2 relative to Stranger 1, whereas the social preferences of the db/db groups for Stranger 2 were weaker than those for Stranger 1. G-CSF treatment did not reverse the social novelty preferences of either the WT or db/db mice ( Figure 2E ). These findings suggest that G-CSF may have modulated the social tendencies but not the social memories of db/db mice.
| G-CSF attenuated reductions in neural activity and improved structural abnormalities in the corpus amygdalae and hippocampi of elderly diabetic mice
The MRI analyses revealed that multiple small vessel abnormalities, including lacunar lesions and tissue atrophy, were present in the brains of db/db mice, particularly in the hippocampus; these abnormal features were less evident in the brains of DGG mice. Additionally, the db/db mice had more lacunar lesions in the hippocampus compared with the WT mice (*P<.05); however, administration of G-CSF had no obvious effects on the presence of the lacunar lesions ( Figure 3A,B) .
Scores on the Scheltens scale 31 can be used to evaluate hippocampal atrophy. As the figure shows in end of the article, the Scheltens scale focuses on three key features of medial temporal lobe atrophy, namely the width of the choroid fissure, the width of the temporal horn, and the height of the hippocampus, which can reflect hippocampal atrophy. Although these studies are from human statistics, it has also the similar reference significance for mice. The DG mice exhibited an increase in hippocampal atrophy compared with the WT mice (*P<.05), but G-CSF did not have any significant effects on such changes ( Figure 3C ).
The functional MRI (fMRI) analyses revealed that the ALFF value of the DG mice was notably lower than that of the WG mice and that the hippocampal connections with surrounding areas were remarkably reduced in db/db mice ( Figure 3E ). Although G-CSF obviously improved the excitability of neurons in the hippocampi and amygdalae and increased connectivity between the hippocampus and surrounding areas in the DG mice, it had no effect on the neural activities of WT mice.
HE staining in the hippocampus of the db/db mice revealed neuronal loss, loose cell arrangements, and other characteristics indicative of cell degeneration, including karyopyknosis ( Figure 4A ). The db/db mice showed significant neuronal loss compared with WG mice (*P<.05), but G-CSF slightly reversed this reduction (*P<.05). A TEM analysis ( Figure 4C ) was performed to identify ultrastructural changes in the hippocampus. Compared with the WT mice, the db/db mice showed a reduction in the number of autophagosomes in the hippocampi (*P<.05), but G-CSF did not have any obvious effects in this regard ( Figure 4D ).
| G-CSF modulated autophagy and inflammationrelated protein expressions in the hippocampi in elderly diabetic mice
The expression of mTOR and the ratio of LC3-II/I in the hippocampi of the db/db groups were lower than those in the WT group. However, G-CSF significantly increased the expressions of Beclin1 and mTOR (*P<.05) and the LC3-II/I ratio (*P<.05) in the DGG mice compared with the DG mice ( Figure 5A,B) . The expression level of the p62 protein in the hippocampi of the DG mice was significantly higher than that of the WG mice, and further reductions were observed in the DGG mice. These findings indicated that there was a decreased level of autophagy in the db/db mice and that G-CSF may exert differential effects on autophagy-related proteins in db/db mice.
The immunohistochemical analyses revealed that the expression levels of NF-κB in the hippocampi of the db/db groups were higher than those in the WG mice and that G-CSF significantly reduced this expression in the DGG mice. Similarly, Western blot analyses showed that the levels of NF-κB in the db/db mice were significantly higher than those in the WT mice and that G-CSF significantly reduced the NF-κB levels in the hippocampi of the db/db mice (*P<.05; Figure 5C ).
These findings indicate that G-CSF may suppress the inflammatory reaction in db/db mice.
| DISCUSSION
Diabetes is a metabolic disease that induces a variety of negative longterm effects including hypoglycemia, free radical-mediated oxidative stress, brain blood vessel reconstruction disorder, and abnormal brain insulin levels, 30, 32 all of which ultimately damage brain function. The present study found that elderly diabetic mice were prone to cognitive dysfunction. At present, the pathogenesis underlying this diabetesrelated cognitive dysfunction remains unclear. However, recently, the relationship between diabetes-related cognitive dysfunction and autophagy impairment has been the focus of academic research. The numbers of neurons in the hippocampal C2 regions of the db/db mice showed an obvious decrease relative to those in the hippocampal C2 regions of the WT mice, but G-CSF improved these lesions in DGG mice (both *P<.05). (C) Alterations in hippocampal ultrastructure examined using a transmission electron microscope (TEM). There was a significant decrease in the number of autophagosomes (red arrow) in db/db mice; G-CSF did not significantly change these numbers. (D) There was a significant decrease in the number of autophagosomes in DG mice compared with WG mice (both *P<.05); G-CSF did not significantly change these numbers. (n=3) As far as the present study is concerned, there are three main ways of autophagy: macro-autophagy, micro-autophagy, and chaperonemediated autophagy. Signaling pathways of mTOR and Beclin-1 are the canonical pathways of macro-autophagy. Macro-autophagy is the most common type of autophagy (hereafter termed simply "autophagy" unless otherwise specified), which is a process that target proteins are engulfed in double-lumen membranes called autophagosomes, and then, autophagosomes is fused to lysosomes which called autophagolysosomes (APLs). [33] [34] [35] [36] When mTORC1 is deactivated, preautophagosomal (phagophores) structures initiated by disinhibition of ULK1 associates with Beclin-1 protein (Atg6). 34, 36, 37 ULK1 activation prompts Beclin-1 to combine VPS34, the class-III PI3K, Barkor, and p150/Vps15 which can form the core of an autophagy-regulating.
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Phagophores are proposed to elongate by two distinct ubiquitination processes to addition of membrane. One of the ubiquitin-like processes involves microtubule-associated protein 1 light chain 3 binding phosphatidyl ethanolamine (PE) (LC3-I→LC3-II conversion). 33, 35, 36, 38, 39 So the magnitude of the LC3-II/I ratio can estimate the level of autophagy. The LC3 proteins seem to play at least two functions. Firstly, they help provide structure within the phagophore which is nascent curvilinear phospholipid domains. Secondly, p62/sequestosome-1 (SQSTM1) containing a short linear LC3-interaction region (LIR) that can bind LC3 proteins as autophagy "tag" or receptor proteins. P62
is incorporated into the autophagosome and then degraded, which is commonly regarded as autophagy substrate protein. The signaling adaptor p62/SQSTM1 activated by NF-κB has been identified as Rasinduced inflammatory and tumorigenesis mediators. 40 More importantly, researchers are now finding that NF-κB also prevent excessive inflammation via a p62/SQSTM1. 41 This may control inflammation reactions and prevent tissue damage.
Autophagy is critical for the maintenance of normal homeostasis and the stability of cellular physiology, 2, 42, 43 particularly during the progression of metabolic syndrome, diabetes, and other diseases. [7] [8] [9] However, the autophagic process acts as a double-edged sword in certain diseases, such as cancer, liver disease, muscular disorders, β-cell mass loss in diabetes, and neurodegenerative diseases. 44 For example, this programmed cell death pathway may have variable outcomes under diabetic conditions 45 and a low degree of activity under physiological conditions and can protect neurons from injury when an organism is properly stressed. On the other hand, a strong stress response will promote cell death and may even hasten the process of various diseases. The efficiency of autophagy decreases with aging, 10 The inhibition of autophagy leads to elevations in intracellular p62 levels in many neurodegenerative diseases. In clinical practice, the maintenance of autophagy with the goal of eliminating p62 plays an important role in the treatment of neurodegenerative diseases.
Similarly, experimental studies have shown that the learning and longterm memory formation abilities of transgenic mice that overexpress p62 may be altered. 55 Also known as sequestosome-1 (SQSTM1), p62
is a scaffold protein that is implicated in stress-induced selective autophagy and plays an important mechanistic role in diabetes. In the present study, there were significant reductions in mTOR levels and in the LC3-II/I ratio in the hippocampi of elderly diabetic DG mice.
Furthermore, immunohistochemical analyses showed that the expression levels of LC3-II/I proteins in the hippocampi of the db/db mice significantly decreased to a level similar to those of the WG mice, whereas the expression levels of NF-κB, an inflammatory signaling molecule, significantly increased. These findings suggest that diabetes may induce autophagic dysfunction and chronic inflammation, which may play key underlying roles in the development of diabetes-related cognitive disorders.
Autophagy is linked to inflammatory signaling pathways via oxidative stress. 56 Inflammation is a fundamental biological process that represents one of the most significant reactions to a variety of acute and chronic pathological processes. Autophagy can induce G-CSF easily penetrates the blood-brain barrier, and many studies have confirmed that it exerts protective effects in the brain. 62, 63 G-CSF significantly enhances the prevention of cell death by affecting the cell edema caused by brain trauma 64 and may promote the proliferation of nerve cells. 65 G-CSF also aids bone marrow stem cells in reaching the blood and areas of brain ischemia which, in turn, protects damaged areas via increased blood flow, the mobilization of neuronal stem cells into neural cells, and the restoration of tissue function. [66] [67] [68] [69] Additionally, the neuroprotective effects of G-CSF may be related to its anti-apoptotic and antiinflammatory activities. 70, 71 It has also been shown that G-CSF promotes the establishment of collateral circulation in the cerebral circle of Willis, which can increase the reserve capacity of cerebral blood vessels. 72 Differentiated neural cells exist in the hippocampus of rats, 73 and the majority of vascular dementia cases caused by chronic cerebral circulation insufficiency is due to stroke or a lacunar infarction. 
| CONCLUSIONS
The present study demonstrated that G-CSF had a preventive intervention effect on cognitive dysfunction in elderly db/db mice with cerebral small vessel disease and that the underlying mechanisms might be related to the regulation of Beclin1-mediated autophagy in the hippocampus, inhibition of NF-κB-mediated local inflammatory reactions, and improvements in the neuronal activity and connectivity of the hippocampus and amygdala. However, the mechanisms associated with the function of G-CSF need to be systematically studied in the near future.
ACKNOWLEDGMENTS
This work was supported by grants from National Natural Scientific 
